Dublin, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The "The Market for In Vitro Diagnostic Tests in Latin America: Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations" report has been added to ResearchAndMarkets.com's offering.

The maturation of in vitro diagnostic (IVD) markets in developed countries have IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new, health-consciousness population with growing demands for quality medical care. Latin America (LATAM) is a key target for IVD manufacturers. This report, The Market for In Vitro Diagnostic Tests in Latin America, focuses on the market for reagents and instruments in the major countries of the continent.

The Total LATAM Market

Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay are also considered, to provide a complete overview of the region.

The report includes the following total market information:

Assessment of Markets by Country

As previously noted, the report takes a deep dive into the IVD markets of Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela. This analysis includes the following data points for each country:

Competitive Landscape

Population growth, government insurance, newly insured patients and updated healthcare facilities will drive growth in the IVD Market in Latin America, attracting the major players in the IVD industry. Roche currently holds the largest percentage of the IVD market in Latin America, with the top five companies participating in the market making up over 60% of the market.

The Market for In Vitro Diagnostic Tests in Latin America presents market share of leading players:

Further, the report provides market participant share by country for Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela by the following IVD market segments:

Market Opportunity by Country Evaluated

Since all the countries in Latin America vary in size, healthcare infrastructure and affordability, in vitro diagnostic companies need to tailor strategies for approaching each countrys market. Tailored strategies are needed for each different country and will assure success if they are conscientiously planned.

The report evaluates the market environments in Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela, assessing the strength of the market opportunity based on the following factors:

The research was carried out during 4Q 2018. Final 2018 revenues were not available for most companies at publication time of the report. Final numbers were adjusted for 2018 totals estimated from 3Q results. Market share is estimated, based on a combination of 2017 results, performance YTD 2018, examination of report market events and interviews.

For more information about this report visit https://www.researchandmarkets.com/research/pl9pll/latin_america?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. 

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics